procainamide has been researched along with Leukopenia in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ream, CR | 1 |
| Barrera, R | 1 |
| Kwan, VW | 1 |
2 other studies available for procainamide and Leukopenia
| Article | Year |
|---|---|
Desensitization to procainamide.
Topics: Agranulocytosis; Arrhythmias, Cardiac; Desensitization, Immunologic; Humans; Leukopenia; Male; Methy | 1970 |
Procaine amide-induced leukopenia.
Topics: Age Factors; Aged; Female; Humans; Leukopenia; Procainamide | 1969 |